Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06575634 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise Therapy on Rheological Functions of Erythrocyte in Hemodialysis

StatusWithdrawn
PhaseNot applicable
Started2022-08-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-17
critical
Trial status changed: Unknown → Withdrawn
Trial withdrawn: The study was not initiated, and no participants were enrolled.
2026-09-06
minor
Trial status changed: Recruiting → Unknown
To improve aerobic capacity, muscular function, and health-related quality of life in patients with end-stage renal disease (ESRD), regular exercise is recommended. Supervised intradialytic exercise at moderate intensity is a viable approach to ensure patient safety, maintain compliance, and effectively enhance physiological adaptations. However, the impact of exercise training on erythrocyte rheological properties in ESRD patients, such as red blood cell deformability, aggregation, and oxygen transport capacity, remains unclear. Method: ESRD patients (anticipated n=180) will undergo supervised exercise training therapy three times per week for six months in the hospital, followed by three months at home. Cardiopulmonary exercise tests will be conducted before and after the intervention. Erythrocyte deformability and aggregation will be assessed using a laser-assisted optical rotational cell analyzer (LORCA), while additional protein levels and reactive oxygen species (ROS) status will be measured using a flow cytometer. This will help determine how exercise affects the rheological properties of red blood cells in this population.
Trial Details
NCT Number NCT06575634
Lead Sponsor Chang Gung Memorial Hospital
Conditions Hemodialysis Complication
Start Date 2022-08-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-16